6 Update information
June 2024
The wording of the recommendation describing the commercial arrangement (see section 1.1), and in section 2.3, has been updated to include procurement information about tocilizumab biosimilars.
ISBN: 978-1-4731-6167-2
June 2024
The wording of the recommendation describing the commercial arrangement (see section 1.1), and in section 2.3, has been updated to include procurement information about tocilizumab biosimilars.
ISBN: 978-1-4731-6167-2